Caloric Vestibular Stimulation for Obsessive-Compulsive Disorder
Study Summary
This trial looks at whether a person with an OCD-related disorder can have a change in their condition by exposing them to a certain type of stimulation.
- Obsessive-Compulsive Disorder
- Body Dysmorphic Disorder
- Health Anxiety
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Are there any eligibility criteria for joining this medical investigation?
"This clinical trial is enrolling 16 individuals, who are over 18 and below 65 years of age and have body dysmorphic disorders. To qualify for this study, participants must also: be within the specified age bracket; possess a primary diagnosis of OCD-related conditions such as BDD, IAD or SSD (excluding "with predominant pain"); not recently changed their psychopharmacological regimen; display strongly held OCRD-connected apprehensions meeting BABS score criterion."
To what extent is capacity being utilized on this research endeavor?
"Affirmative. The details on clinicaltrials.gov indicate that this trial is actively enrolling participants, with the initial posting date being May 10th 2022 and an update occurring November 7th of the same year. A total of 16 patients are expected to be recruited from a single site."
Is the trial currently recruiting participants?
"Affirmative. Clinicaltrials.gov indicates that this clinical trial began recruiting on May 10th 2022 and was last amended November 7th of the same year. 16 volunteers are required to join from a single medical centre."
Does this experiment accept those older than 55 years of age?
"This medical experiment has an age limit of 18 to 65 years old. Currently, there are 338 studies for those under the lower bracket and 864 trials that cater to patients over 65."